Casaevades

Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.

Por um escritor misterioso
Last updated 11 novembro 2024
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Type III CRISPR–Cas provides resistance against nucleus-forming jumbo phages via abortive infection
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
The Rcs stress response inversely controls surface and CRISPR–Cas adaptive immunity to discriminate plasmids and phages
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Frontiers Biological and Molecular Characterization of a Jumbo Bacteriophage Infecting Plant Pathogenic Ralstonia solanacearum Species Complex Strains
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
PDF) A nucleus-forming jumbophage evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Subcellular organization of viral particles during maturation of nucleus-forming jumbo phage
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
The shell and tubulin proteins in Serratia jumbo phage PCH45 possess
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
IJMS, Free Full-Text
Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Huge bacteriophages: bridging the gap? - Brüssow - 2020 - Environmental Microbiology - Wiley Online Library
Recomendado para você
você pode gostar

© 2014-2024 vasevaults.com. All rights reserved.